tiprankstipranks
Petros Pharmaceuticals Amends President’s Employment Terms
Company Announcements

Petros Pharmaceuticals Amends President’s Employment Terms

An update from Petros Pharmaceuticals ( (PTPI) ) is now available.

Don't Miss Our Christmas Offers:

Petros Pharmaceuticals has amended its employment agreement with President Fady Boctor, allowing him to engage in other consulting roles, provided no conflicts arise. The amendment also adjusts his salary to $280,000 annually and sets the employment term to end on December 31, 2024. This move could signal strategic adjustments within the company’s leadership structure.

Find detailed analytics on PTPI stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyPetros to shift focus to development of tech as Rx-to-OTC switch solution
TipRanks Auto-Generated NewsdeskBoard Reshuffle at Petros Pharmaceuticals Following Resignations
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App